Daniel A. Camardo's most recent trade in Cue Biopharma Inc was a trade of 21,800 Common Stock done . Disclosure was reported to the exchange on July 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Daniel A. Camardo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 21,800 | 21,800 (0%) | 0% | 0 | Common Stock | |
| Cue Biopharma Inc | Daniel A. Camardo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2026 | 1,626 | 1,626 | - | - | Stock Option (Right to Buy) | |
| Athersys Inc | Daniel Camardo A. | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share. | 04 Oct 2023 | 19,993 | 285,341 (0%) | 0% | 0.4 | 8,797 | Common Stock |
| Athersys Inc | Daniel A. Camardo | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.91 per share. | 05 Jul 2023 | 19,993 | 305,334 (0%) | 0% | 0.9 | 18,274 | Common Stock |
| Athersys Inc | Daniel A. Camardo | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. | 04 Apr 2023 | 19,993 | 325,327 (0%) | 0% | 1 | 19,993 | Common Stock |
| Athersys Inc | Daniel A. Camardo | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. | 04 Jan 2023 | 23,484 | 345,320 (0%) | 0% | 0.8 | 19,961 | Common Stock |
| Athersys Inc | Daniel A. Camardo | Director, CEO | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 22 Nov 2022 | 100,000 | 368,804 (0%) | 0% | 0.5 | 54,960 | Common Stock |
| Athersys Inc | Daniel A. Camardo | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2022 | 263,492 | 268,804 (0%) | 0% | 0 | Common Stock | |
| Athersys Inc | Daniel A. Camardo | Director, CEO | Purchase of securities on an exchange or from another person at price $ 0.77 per share. | 17 Mar 2022 | 132,800 | 132,800 (0%) | 0% | 0.8 | 102,256 | Common Stock |
| Athersys Inc | Daniel A. Camardo | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 4,000,000 | 4,000,000 | - | - | Stock Option (right to purchase) |